Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pendleton

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2019
In Vitro Assays to Monitor the Enzymatic Activities of zDHHC Protein AcyltransferasesDavid A Mitchell, Laura C Pendleton, Robert J Deschenes
Plant Molecular Biology|November 1, 1993
Molecular characterization of maize extensin expressionE E Hood, J M Murphy, R C Pendleton
Hospital Practice (1995)|May 18, 2010
Pulmonary embolism with unexpected echocardiogram findingsKencee K Graves, Larry S Green, Robert C Pendleton
Clinics in Chest Medicine|November 5, 2010
Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopeniaRobert C Pendleton, George M Rodgers, Russell D Hull
Biochimica Et Biophysica Acta|April 14, 1988
In situ determination of the functional size of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase by radiation inactivation analysisG C Ness, L C Pendleton, M J McCreery
Experimental Biology and Medicine (Maywood, N.J.)|June 30, 2005
Target size analysis by radiation inactivation: the use of free radical scavengersGene C Ness, Laura C Pendleton, Michael J McCreery
The Journal of Biological Chemistry|August 15, 1991
Feedback regulation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity by dietary cholesterol is not due to altered mRNA levelsG C Ness, R K Keller, L C Pendleton
Lipids|June 1, 1987
Loss of NADPH during assays of HMG-CoA reductase: implications and approaches to minimize errorsG C Ness, L C Pendleton, A S Pendleton
Expert Review of Clinical Pharmacology|November 26, 2011
Current challenges in personalizing warfarin therapyGwendolyn A McMillin, Sara R Vazquez, Robert C Pendleton
Expert Review of Cardiovascular Therapy|November 27, 2010
Prevention of venous thromboembolism in obesityAndrew L Freeman, Robert C Pendleton, Matthew T Rondina
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2019
In Vitro Assays to Monitor the Enzymatic Activities of zDHHC Protein AcyltransferasesDavid A Mitchell, Laura C Pendleton, Robert J Deschenes
Plant Molecular Biology|November 1, 1993
Molecular characterization of maize extensin expressionE E Hood, J M Murphy, R C Pendleton
Hospital Practice (1995)|May 18, 2010
Pulmonary embolism with unexpected echocardiogram findingsKencee K Graves, Larry S Green, Robert C Pendleton
Clinics in Chest Medicine|November 5, 2010
Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopeniaRobert C Pendleton, George M Rodgers, Russell D Hull
Biochimica Et Biophysica Acta|April 14, 1988
In situ determination of the functional size of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase by radiation inactivation analysisG C Ness, L C Pendleton, M J McCreery
Experimental Biology and Medicine (Maywood, N.J.)|June 30, 2005
Target size analysis by radiation inactivation: the use of free radical scavengersGene C Ness, Laura C Pendleton, Michael J McCreery
The Journal of Biological Chemistry|August 15, 1991
Feedback regulation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity by dietary cholesterol is not due to altered mRNA levelsG C Ness, R K Keller, L C Pendleton
Lipids|June 1, 1987
Loss of NADPH during assays of HMG-CoA reductase: implications and approaches to minimize errorsG C Ness, L C Pendleton, A S Pendleton
Expert Review of Clinical Pharmacology|November 26, 2011
Current challenges in personalizing warfarin therapyGwendolyn A McMillin, Sara R Vazquez, Robert C Pendleton
Expert Review of Cardiovascular Therapy|November 27, 2010
Prevention of venous thromboembolism in obesityAndrew L Freeman, Robert C Pendleton, Matthew T Rondina
Pageof 9